Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | CASR | P41180 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL61312 | 0.88 | KDM4E (0.42) | KDM4ECASRUSP2HTT | |
| SCHEMBL14076652 | 0.87 | KDM4E (0.40) | KDM4ECASRHSD17B10USP2HTT | |
| SCHEMBL15218970 | 0.86 | KDM4E (0.41) | KDM4ECASRUSP2HTT | |
| SCHEMBL62207 | 0.86 | KDM4E (0.41) | KDM4ECASRUSP2HTT | |
| SCHEMBL15218997 | 0.85 | KDM4E (0.40) | KDM4ECASRUSP2HTT | |
| SCHEMBL9928007 | 0.84 | KDM4E (0.42) | KDM4ECASRHSD17B10USP2HTT | |
| SCHEMBL9804472 | 0.84 | KDM4E (0.39) | KDM4ECASRHSD17B10USP2HTT | |
| SCHEMBL18102291 | 0.84 | KDM4E (0.39) | KDM4ECASRUSP2HTT | |
| SCHEMBL9927969 | 0.84 | KDM4E (0.39) | KDM4ECASRUSP2HTT | |
| SCHEMBL19697517 | 0.84 | POLB (0.42) | KDM4ECASR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2678343-B1 | REDUCING ALUMINOSILICATE SCALE IN THE BAYER PROCESS | NALCO CO (US) | 2021-09-22 | — | — | EP | disclosed |
| US-9944534-B2 | Reducing aluminosilicate scale in the Bayer process | ECOLAB USA INC. (US) | 2018-04-17 | — | — | US | disclosed |
| US-9944534-B2 | Reducing aluminosilicate scale in the Bayer process | ECOLAB USA INC. (US) | 2018-04-17 | — | — | US | disclosed |
| US-20170050861-A1 | Reducing Aluminosilicate Scale in the Bayer Process | NALCO COMPANY (US) | 2017-02-23 | — | — | US | disclosed |
| US-20170050861-A1 | Reducing Aluminosilicate Scale in the Bayer Process | NALCO COMPANY (US) | 2017-02-23 | — | — | US | disclosed |
| US-9487408-B2 | Reducing aluminosilicate scale in the bayer process | NALCO COMPANY (US) | 2016-11-08 | — | — | US | disclosed |
| US-9487408-B2 | Reducing aluminosilicate scale in the bayer process | NALCO COMPANY (US) | 2016-11-08 | — | — | US | disclosed |
| US-8889096-B2 | Reducing aluminosilicate scale in the bayer process | NALCO COMPANY (US) | 2014-11-18 | — | — | US | disclosed |
| US-8889096-B2 | Reducing aluminosilicate scale in the bayer process | NALCO COMPANY (US) | 2014-11-18 | — | — | US | disclosed |
| WO-2013126683-A1 | REDUCING ALUMINOSILICATE SCALE IN THE BAYER PROCESS | NALCO COMPANY (US) | 2013-08-29 | — | — | WO | disclosed |
| US-20120148462-A1 | REDUCING ALUMINOSILICATE SCALE IN THE BAYER PROCESS | ECOLAB USA INC. | 2012-06-14 | — | — | US | disclosed |
| US-20120148462-A1 | REDUCING ALUMINOSILICATE SCALE IN THE BAYER PROCESS | ECOLAB USA INC. | 2012-06-14 | — | — | US | disclosed |
| US-20110212006-A1 | REDUCING ALUMINOSILICATE SCALE IN THE BAYER PROCESS | ECOLAB USA INC. | 2011-09-01 | — | — | US | disclosed |
| US-20110212006-A1 | REDUCING ALUMINOSILICATE SCALE IN THE BAYER PROCESS | ECOLAB USA INC. | 2011-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170050861-A1 | Reducing Aluminosilicate Scale in the Bayer Process | DSP, SOST, SORD | KDM4E 3063/4885CASR 612/4885HSD17B10 4140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.